Modulatory effects of phosphatidylserine on the binding of muscarinic cholinergic receptor ligands. Studies in vitro and in vivo

Molecular and Chemical Neuropathology
S RaskovskyD Jerusalinsky

Abstract

The modulation of the binding of muscarinic cholinergic receptor ligands by phosphatidylserine purified from bovine cerebral cortex (BC-PS) was examined in vitro and in vivo. The enrichment of bovine cerebral cortical synaptosomal membranes with BC-PS, using a fusion technique, produced a concentration-dependent decrease in the affinity (increase in Kd) of [3H]quinuclidinyl benzylate (3H-QNB) specific binding to muscarinic acetylcholine receptors (mAChR), without changes in their maximal number (Bmax). Similar results were observed when [3H]oxotremorine (3H-OXO) was used to label a high affinity subpopulation of mAChR. On the other hand, preincubation of BC-PS liposomes with synaptosomal membranes in a nonoptimum fusion condition (at pH 7.4) did not alter the binding properties of both radioligands. Fusion experiments using a pure phosphatidylserine preparation from spinal cord revealed a similar decrement in the affinity of 3H-QNB specific binding. Five day's intraperitoneal (i.p.) administration of 15 mg/kg of BC-PS liposomes in rats increased the maximal number of cerebral cortical binding sites for 3H-OXO. Scatchard analysis revealed no changes in the apparent dissociation constant. This modification is selective in relatio...Continue Reading

References

Sep 15, 1977·Biochemical Pharmacology·R S AronstamJ Baumgold
May 1, 1979·Archives of Biochemistry and Biophysics·T J AndreasenM G McNamee
Sep 1, 1976·European Journal of Pharmacology·L G Abood, F Takeda
Mar 25, 1976·Nature·A BruniE Boarato
Jan 1, 1987·Annual Review of Neuroscience·N M Nathanson
Jan 1, 1989·Brain Research. Molecular Brain Research·M Levi de SteinE De Robertis
May 7, 1987·European Journal of Pharmacology·J R Hammond, I L Martin
Mar 1, 1988·Metabolic Brain Disease·A A FarooquiL A Horrocks
Jan 1, 1986·Psychopharmacology·A ZanottiG Toffano
Feb 1, 1986·Acta Neurologica Scandinavica·P J DelwaideM Ylieff
Apr 1, 1966·Life Sciences·E De RobertisJ M Azcurra
Jun 1, 1984·Journal of Autonomic Pharmacology·H SiegelD J Triggle
Jan 1, 1980·Annual Review of Pharmacology and Toxicology·H H Loh, P Y Law
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Jun 24, 1982·Brain Research·A C FosterC W Cotman
Aug 1, 1984·Journal of Neurochemistry·C R OliveiraA P Carvalho
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·H SchneiderC R Hackenbrock

❮ Previous
Next ❯

Citations

Oct 29, 2000·Archives of Biochemistry and Biophysics·C D'AntuonoD L Bernik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.